Skip to content

Author

Luluah M. Al Masoudi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

Phytochemical profiling and in vitro antioxidant, cytotoxic, and digestive enzyme inhibitory activities of ethanolic fenugreek (Trigonella foenum-graecum L.) seed extract

Trigonella foenum-graecum L. (fenugreek) is a medicinal and culinary plant valued for its rich phytochemical composition and diverse biological activities. This study investigated the phytochemical profile and in vitro biological activities of an ethanolic fenugreek seed extract using chromatographic and biological assays. GC–MS analysis tentatively identified nineteen volatile constituents, with 2-methyl-2-butenal (36.65%) and p-cymene (17.96%) as the major compounds, while HPLC revealed a phenolic-rich extract. The extract exhibited concentration-dependent antioxidant activity, reaching 85.75 ± 1.73% and 71.79 ± 1.95% scavenging in the DPPH and ABTS assays, respectively, at 1000 µg/mL. MTT evaluation demonstrated preferential cytotoxicity toward HepG2 and Caco-2 cancer cells, with IC₅₀ values of 124.65 and 164.39 µg/mL, respectively, compared with 480.8 µg/mL for normal WI-38 cells. The extract also showed moderate pancreatic lipase inhibitory activity (IC₅₀ = 116.74 µg/mL) compared with orlistat (IC₅₀ = 17.83 µg/mL) and dose-dependently inhibited α-amylase and α-glucosidase. Collectively, these findings demonstrate the extract’s in vitro antioxidant activity, preferential cytotoxicity toward the tested cancer cell lines, and inhibitory effects on pancreatic lipase and carbohydrate-digesting enzymes.

N. H. Aljarba, M. Khormi, Hamida Hamdi et al. · 0 citations
Open access Jul 2026

Evaluation of early antioxidant and anti-inflammatory effects of Ecballium elaterium (L.) A. rich balm in rats with imiquimod-induced psoriasis

Psoriasis is a persistent cutaneous disorder involving an imbalance in immune regulation, oxidative stress, and abnormal epidermal proliferation. This study evaluated the therapeutic efficacy of Ecballium elaterium (EE) balm compared with clobetasol propionate (0.05%) (CLO) in rats with psoriasis-like lesions induced by topical imiquimod (IMQ). A total of twenty-four adult male of the Wistar strain were randomly allocated to four groups comprising: control (healthy rats), IMQ-induced psoriasis, IMQ + EE balm, and IMQ + clobetasol. Psoriasis was induced by topical application of 5% imiquimod. Treatments were administered daily. Disease severity, histological changes, oxidative stress markers, serum tumor necrosis factor-α (TNF-α), and biochemical parameters were evaluated. EE balm markedly improved psoriatic lesions and reduced psoriasis severity scores in imiquimod-treated rats. Biochemical analyses indicated that EE balm produced fewer disturbances in hepatic and lipid parameters than clobetasol, notably by preventing alanine aminotransferase elevation (EE: 62.20 ± 3.09; CLO: 89 ± 6.08) and lowering total cholesterol (EE: 0.47 ± 0.08; CLO: 0.63 ± 0.03). However, serum triglyceride (EE: 0.61 ± 0.03) and creatinine concentrations (EE: 6.03 ± 0.23) remained elevated. Serum TNF-α levels, markedly elevated in imiquimod-treated rats, were significantly reduced following EE balm and clobetasol treatments compared with the IMQ experimental set (p < 0.001). EE balm also mitigated oxidative stress by lowering thiobarbituric acid reactive substances (TBARS) levels in serum and erythrocytes in the IMQ group. It also restored antioxidant activities, including catalase (IMQ: 3.06 ± 0.79; EE: 4.24 ± 0.73), super oxide dismutase (IMQ: 03.17 ± 1.01; EE: 18.24 ± 1.90), glutathione peroxidase (EE: 31.25 ± 4.99). Additionally, glutathione s-transferase activity was improved in serum and erythrocytes (EE: 09.96 ± 2.29), as were reduced glutathione levels (IMQ: 0.0021 ± 0.0007; EE: 0.0042 ± 0.001). In an imiquimod-induced psoriasis rat model, Ecballium elaterium balm reduced disease severity, oxidative stress, and inflammatory markers, with systemic biochemical changes. Despite these promising findings, this research is still in its early stages based on a single preclinical model.

D. N. Benmalek, F. E. El kadi, Aicha Benyahia et al. · 0 citations